Nitish Badhwar, MD
Cardiovascular Disease (Cardiology) · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Offices
- 2
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Ahmc Seton Medical Center · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Badhwar’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A76074 · Current
Licensed to practise in California · since 2001 · expires 2028-10-31 · University of Delhi, Maulana Azad Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ahmc Seton Medical CenterDaly City, CAAcute Care Hospital · Proprietary · Has an emergency departmentPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Ahmc Seton Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 229 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.49 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 34 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.5 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.9 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.9 · 36 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 739 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 1,636 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.51) · 1,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.1 to 4.43) · 361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.62 (0 to 18.38) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.98 (1.71 to 10.25) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 73 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 1,387 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 30 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 77 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 190 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.4 · 53 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 63.8 · 154 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 258 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 48 cases | No different | Jan 2022 – Dec 2024 |
What patients said (257 patients answered, 20% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$166,049
Medicare paid this office $166,049 for 608 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 38 | $29,825 | $785 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 27 | $20,746 | $692 |
| Long return visit (40+ min) | 101 | $17,293 | $156 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 13 | $11,662 | $833 |
| Long return visit (40+ min) | 75 | $10,747 | $121 |
See all 21 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 38 | $29,825 | $785 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 27 | $20,746 | $692 |
| Long return visit (40+ min) | 101 | $17,293 | $156 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 13 | $11,662 | $833 |
| Long return visit (40+ min) | 75 | $10,747 | $121 |
| New patient visit (60+ min) | 51 | $10,647 | $209 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $8,181 | $106 |
| New patient visit (60+ min) | 51 | $7,985 | $157 |
| Hospital discharge day management, more than 30 minutes | 62 | $6,587 | $103 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 23 | $6,338 | $254 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 11 | $4,896 | $445 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 11 | $4,582 | $255 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 41 | $3,001 | $73 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 215 | $1,691 | $7 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,518 | $117 |
| Programming of heart rhythm stimulation after drug infusion | 24 | $1,449 | $60 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 21 | $1,388 | $63 |
| Programming of dual lead pacemaker system | 18 | $657 | $30 |
| Programming of dual lead implantable defibrillator system | 12 | $651 | $50 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $425 | $33 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 34 | $387 | $11 |
Procedures Medicare counted
| Pacemaker insertion or repair | 31 | More than 79% of doctors who do this |
Who their Medicare patients are
608 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 14% · Women 49% · Also on Medicaid 23% · Health risk score 1.83. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Atrial fibrillation 65% · Coronary heart disease 53% · Heart failure 49% · Chronic kidney disease 42% · Diabetes 39% · Depression 22% · Cancer 18% · COPD 17% · Stroke 14% · Dementia 10%.
The office billed $1,255,757, Medicare allowed $212,777 and paid $166,049; for 1,110 services of 57 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 608 | 1,110 | 75 | 1.83 | $1,255,757 | $166,049 |
| 2023 | 542 | 987 | 75 | 1.94 | $1,271,703 | $157,007 |
| 2022 | 553 | 1,131 | 75 | 1.70 | $1,219,555 | $165,226 |
| 2021 | 280 | 654 | 74 | 1.80 | $1,084,209 | $159,349 |
| 2020 | 296 | 644 | 74 | 1.83 | $776,539 | $124,264 |
| 2019 | 263 | 586 | 74 | 1.74 | $429,114 | $89,104 |
| 2018 | 262 | 608 | 74 | 2.01 | $635,351 | $118,197 |
| 2017 | 434 | 1,000 | 75 | 1.92 | $794,335 | $124,651 |
| 2016 | 434 | 1,075 | 75 | 2.06 | $783,925 | $118,720 |
| 2015 | 847 | 1,603 | 73 | 2.17 | $946,001 | $149,389 |
| 2014 | 732 | 1,481 | 73 | 2.04 | $842,969 | $133,331 |
| 2013 | 588 | 1,400 | 74 | 2.06 | $874,738 | $141,735 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 42 | $34,578 | $823 |
| Long return visit (40+ min) | 171 | $24,984 | $124 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 16 | $17,436 | $872 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 17 | $12,347 | $726 |
| New patient visit (60+ min) | 80 | $12,314 | $154 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 34 | $11,487 | $267 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 11 | $4,815 | $438 |
| Hospital discharge day management, more than 30 minutes | 37 | $4,177 | $107 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 11 | $2,944 | $268 |
| Insertion of tube in left heart chamber through heart septum | 14 | $2,519 | $180 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 23 | $1,803 | $69 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,678 | $73 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 186 | $1,503 | $7 |
| Programming of heart rhythm stimulation after drug infusion | 15 | $1,188 | $79 |
| Programming of dual lead pacemaker system | 19 | $764 | $33 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 30 | $718 | $23 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 19 | $662 | $33 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 20 | $551 | $28 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 13 | $264 | $20 |
2022: 20 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 29 | $27,332 | $942 |
| Long return visit (40+ min) | 135 | $19,885 | $120 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 17 | $18,438 | $970 |
| New patient visit (60+ min) | 113 | $18,183 | $161 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 17 | $11,966 | $704 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 25 | $7,850 | $271 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,232 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $4,950 | $93 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 43 | $2,285 | $35 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 47 | $2,123 | $28 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 77 | $2,005 | $24 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 21 | $1,869 | $89 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,767 | $98 |
| New patient visit (45+ min) | 13 | $1,609 | $124 |
| Programming of heart rhythm stimulation after drug infusion | 13 | $1,317 | $101 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,116 | $66 |
| Programming of dual lead pacemaker system | 23 | $1,084 | $35 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 26 | $1,032 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 95 | $826 | $8 |
| Programming of multiple lead implantable defibrillator system | 12 | $747 | $57 |
2021: 17 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 22 | $22,881 | $995 |
| Long return visit (40+ min) | 122 | $20,064 | $132 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 18 | $17,905 | $995 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 19 | $14,058 | $740 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 39 | $10,500 | $262 |
| New patient visit (60+ min) | 59 | $9,857 | $167 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 17 | $7,847 | $462 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 18 | $7,159 | $377 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 49 | $5,755 | $115 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 12 | $4,985 | $415 |
| Insertion of tube in left heart chamber through heart septum | 20 | $3,736 | $187 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 30 | $3,143 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $3,142 | $185 |
| Programming of heart rhythm stimulation after drug infusion | 22 | $2,871 | $130 |
| Telephone medical discussion with physician, 21-30 minutes | 25 | $2,328 | $90 |
| Return visit (30+ min) | 18 | $1,672 | $93 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 14 | $407 | $25 |
2020: 19 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 11 | $13,946 | $996 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 12 | $11,954 | $996 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 14 | $10,674 | $762 |
| New patient visit (60+ min) | 64 | $9,492 | $148 |
| Long return visit (40+ min) | 87 | $8,991 | $92 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 29 | $7,742 | $267 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 16 | $7,282 | $455 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 35 | $4,998 | $135 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 12 | $4,931 | $379 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $4,139 | $125 |
| Insertion of tube in left heart chamber through heart septum | 14 | $2,673 | $191 |
| New patient visit (60+ min) | 12 | $1,953 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,535 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,519 | $66 |
| Return visit (30+ min) | 19 | $1,384 | $73 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $891 | $69 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 22 | $537 | $24 |
| Programming of multiple lead implantable defibrillator system | 11 | $519 | $47 |
| Programming of dual lead pacemaker system | 14 | $422 | $28 |
2019: 14 services
| Long return visit (40+ min) | 103 | $11,438 | $96 |
| New patient visit (60+ min) | 67 | $9,712 | $145 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 13 | $9,570 | $736 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 23 | $5,998 | $261 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 16 | $2,134 | $133 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,105 | $124 |
| Return visit (30+ min) | 27 | $1,939 | $69 |
| Programming of multiple lead implantable defibrillator system | 21 | $1,753 | $58 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 16 | $1,659 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,585 | $66 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,364 | $91 |
| Programming of dual lead pacemaker system | 31 | $1,248 | $34 |
| Programming of dual lead implantable defibrillator system | 11 | $545 | $42 |
| Programming of cardiac rhythm monitor system | 12 | $340 | $23 |
2018: 18 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 18 | $17,506 | $973 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 12 | $12,597 | $969 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 28 | $8,269 | $285 |
| New patient visit (60+ min) | 50 | $7,466 | $149 |
| Long return visit (40+ min) | 61 | $6,484 | $95 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 27 | $3,550 | $131 |
| Implantation patient-activated heart monitoring device | 16 | $3,178 | $199 |
| New patient visit (60+ min) | 11 | $2,079 | $189 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,982 | $180 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,954 | $122 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 13 | $1,332 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,307 | $65 |
| Programming of dual lead pacemaker system | 30 | $1,258 | $32 |
| Programming of multiple lead implantable defibrillator system | 14 | $1,149 | $55 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $986 | $90 |
| Return visit (30+ min) | 14 | $918 | $66 |
| Programming of dual lead implantable defibrillator system | 12 | $844 | $53 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 14 | $388 | $18 |
2017: 21 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 30 | $29,687 | $958 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 38 | $13,449 | $345 |
| Long return visit (40+ min) | 55 | $5,186 | $91 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 14 | $4,993 | $357 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 35 | $4,731 | $131 |
| Return visit (30+ min) | 74 | $4,427 | $54 |
| New patient visit (45+ min) | 41 | $4,381 | $107 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,168 | $174 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 36 | $3,161 | $23 |
| New patient visit (60+ min) | 24 | $3,049 | $127 |
| Programming of dual lead pacemaker system | 62 | $2,944 | $29 |
| Programming of heart rhythm stimulation after drug infusion | 21 | $2,930 | $140 |
| Programming of multiple lead implantable defibrillator system | 32 | $2,797 | $51 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,823 | $122 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,786 | $89 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 15 | $1,541 | $103 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 17 | $1,156 | $55 |
| Programming of dual lead implantable defibrillator system | 15 | $1,007 | $44 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 18 | $645 | $27 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 50 | $439 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 12 | $68 | $6 |
2016: 23 services
| Return visit (30+ min) | 167 | $14,454 | $62 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 12 | $12,632 | $972 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 24 | $8,174 | $341 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $8,005 | $728 |
| New patient visit (60+ min) | 41 | $5,562 | $136 |
| Long return visit (40+ min) | 51 | $4,896 | $87 |
| Programming of multiple lead implantable defibrillator system | 40 | $4,828 | $54 |
| Programming of dual lead pacemaker system | 71 | $3,291 | $31 |
| New patient visit (45+ min) | 31 | $3,268 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,218 | $179 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 36 | $2,552 | $23 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 18 | $2,331 | $130 |
| Programming of heart rhythm stimulation after drug infusion | 13 | $1,784 | $137 |
| Programming of dual lead implantable defibrillator system | 23 | $1,752 | $43 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,327 | $121 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 14 | $1,312 | $94 |
| External shock to heart to regulate heart beat | 11 | $1,221 | $111 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 16 | $1,096 | $58 |
| Programming of single lead implantable defibrillator system | 11 | $743 | $35 |
| Programming of multiple lead pacemaker system | 14 | $734 | $39 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 18 | $614 | $31 |
| Programming of single lead pacemaker system | 12 | $429 | $27 |
| Programming of cardiac rhythm monitor system | 14 | $405 | $18 |
2015: 23 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 21 | $20,705 | $986 |
| Return visit (30+ min) | 160 | $13,808 | $64 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 29 | $10,336 | $345 |
| Long return visit (40+ min) | 77 | $8,893 | $97 |
| New patient visit (60+ min) | 42 | $6,089 | $145 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,804 | $181 |
| Programming of multiple lead implantable defibrillator system | 53 | $5,285 | $53 |
| New patient visit (45+ min) | 37 | $4,188 | $113 |
| Removal and replacement of multiple lead defibrillator | 11 | $3,731 | $339 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 409 | $3,595 | $7 |
| Programming of dual lead pacemaker system | 71 | $3,391 | $33 |
| Implantation patient-activated heart monitoring device | 15 | $3,251 | $217 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 23 | $3,017 | $131 |
| Programming of heart rhythm stimulation after drug infusion | 17 | $2,366 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,343 | $94 |
| Programming of dual lead implantable defibrillator system | 22 | $2,049 | $51 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 19 | $1,939 | $102 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,806 | $90 |
| Programming of single lead implantable defibrillator system | 18 | $1,402 | $35 |
| External shock to heart to regulate heart beat | 12 | $1,349 | $112 |
| Programming of multiple lead pacemaker system | 15 | $987 | $35 |
| Programming of single lead pacemaker system | 20 | $792 | $29 |
| Programming of cardiac rhythm monitor system | 17 | $738 | $23 |
2014: 20 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 12 | $13,596 | $971 |
| Return visit (30+ min) | 141 | $13,155 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $10,995 | $180 |
| Programming of multiple lead implantable defibrillator system | 56 | $7,643 | $53 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 19 | $7,460 | $339 |
| New patient visit (60+ min) | 47 | $6,540 | $139 |
| Long return visit (40+ min) | 63 | $6,170 | $92 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 14 | $5,612 | $401 |
| Programming of dual lead pacemaker system | 59 | $3,612 | $33 |
| New patient visit (45+ min) | 29 | $3,329 | $115 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 317 | $2,984 | $7 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 17 | $2,608 | $130 |
| Programming of dual lead implantable defibrillator system | 22 | $1,971 | $48 |
| Programming of heart rhythm stimulation after drug infusion | 11 | $1,519 | $138 |
| Programming of single lead implantable defibrillator system | 19 | $1,423 | $36 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 13 | $1,421 | $101 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 16 | $1,402 | $88 |
| Short return visit (20+ min) | 28 | $1,099 | $39 |
| Programming of multiple lead pacemaker system | 13 | $905 | $38 |
| Programming of single lead pacemaker system | 14 | $410 | $27 |
2013: 23 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 14 | $12,961 | $926 |
| Return visit (30+ min) | 124 | $11,083 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $10,379 | $176 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 14 | $9,712 | $694 |
| Programming of multiple lead implantable defibrillator system | 68 | $9,237 | $49 |
| Long return visit (40+ min) | 71 | $8,042 | $90 |
| New patient visit (60+ min) | 55 | $7,794 | $142 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 19 | $6,127 | $322 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 13 | $4,766 | $367 |
| Removal and replacement of multiple lead defibrillator | 12 | $4,258 | $355 |
| Programming of dual lead pacemaker system | 66 | $3,446 | $29 |
| New patient visit (45+ min) | 26 | $2,480 | $95 |
| Programming of dual lead implantable defibrillator system | 22 | $2,393 | $47 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 17 | $2,101 | $124 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,906 | $119 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 21 | $1,731 | $82 |
| Programming of multiple lead pacemaker system | 20 | $1,428 | $36 |
| External shock to heart to regulate heart beat | 12 | $1,400 | $108 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 162 | $1,400 | $7 |
| Programming of single lead implantable defibrillator system | 20 | $1,346 | $32 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 15 | $962 | $48 |
| Hospital discharge day management, 30 minutes or less | 12 | $778 | $65 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 21 | $467 | $22 |
Medicaid work
$2,005 in 2024
Medicaid paid $2,005 for 189 billed services this clinician did in 2024, up to 140 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 189 | $2,005 |
| 2024 | 189 | 1 | 140 | $2,005 |
| 2023 | 149 | 2 | 63 | $2,408 |
| 2022 | 290 | 2 | 79 | $2,899 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 136 | $1,471 |
| Long return visit (40+ min) | 13 | $937 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 268 | $2,390 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 22 | $509 |
Drugs they prescribed that Part D paid
$337,650
Pharmacies billed $337,650 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 780) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
536 generic and 244 brand-name prescriptions · $337,650 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 178 | $201,179 | $1,130 |
| Xarelto | 57 | $71,724 | $1,258 |
| Dofetilide | 136 | $35,855 | $264 |
| Propafenone Hcl Er | 44 | $12,162 | $276 |
| Flecainide Acetate | 64 | $3,784 | $59 |
See all 10 drugs
| Eliquis | 178 | $201,179 | $1,130 |
| Xarelto | 57 | $71,724 | $1,258 |
| Dofetilide | 136 | $35,855 | $264 |
| Propafenone Hcl Er | 44 | $12,162 | $276 |
| Flecainide Acetate | 64 | $3,784 | $59 |
| Metoprolol | 117 | $2,186 | $19 |
| Sotalol | 42 | $1,323 | $32 |
| Diltiazem 24hr Er (Cd) | 20 | $620 | $31 |
| Carvedilol | 18 | $212 | $12 |
| Metoprolol | 34 | $135 | $4 |
Year by year
| 2024 | 780 | 191 | 0% (0) | 31% | $337,650 |
| 2023 | 762 | 191 | 0% (0) | 31% | $361,750 |
| 2022 | 702 | 184 | 0% (0) | 32% | $333,760 |
| 2021 | 706 | 172 | 0% (0) | 31% | $288,991 |
| 2020 | 534 | 122 | 0% (0) | 35% | $203,009 |
| 2019 | 502 | 102 | 0% (0) | 35% | $141,078 |
| 2018 | 308 | 94 | 0% (0) | 44% | $85,979 |
| 2017 | 317 | 98 | None | 43% | $86,441 |
| 2016 | 561 | 138 | 0% (0) | 48% | $171,055 |
| 2015 | 564 | 150 | None | 51% | $153,284 |
| 2014 | 675 | 139 | None | 43% | $138,719 |
| 2013 | 630 | 116 | 0% (0) | 31% | $89,570 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Eliquis | 165 | $200,629 | $1,216 |
| Xarelto | 58 | $72,668 | $1,253 |
| Dofetilide | 111 | $41,064 | $370 |
| Multaq | 12 | $11,605 | $967 |
| Propafenone Hcl Er | 22 | $11,032 | $501 |
| Dabigatran Etexilate | 16 | $6,895 | $431 |
| Flecainide Acetate | 74 | $5,712 | $77 |
| Metoprolol | 113 | $2,746 | $24 |
| Sotalol | 40 | $2,451 | $61 |
| Carvedilol | 16 | $561 | $35 |
| Diltiazem 24hr Er (Cd) | 19 | $515 | $27 |
| Pantoprazole | 31 | $251 | $8 |
| Metoprolol | 28 | $238 | $8 |
2022: 12 drugs
| Eliquis | 163 | $163,382 | $1,002 |
| Xarelto | 47 | $70,914 | $1,509 |
| Dofetilide | 114 | $57,866 | $508 |
| Multaq | 11 | $12,846 | $1,168 |
| Propafenone Hcl Er | 18 | $9,872 | $548 |
| Flecainide Acetate | 52 | $4,459 | $86 |
| Metoprolol | 97 | $1,965 | $20 |
| Sotalol | 22 | $1,021 | $46 |
| Diltiazem 24hr Er (Cd) | 25 | $831 | $33 |
| Pantoprazole | 40 | $450 | $11 |
| Amiodarone | 20 | $423 | $21 |
| Metoprolol | 30 | $246 | $8 |
2021: 13 drugs
| Eliquis | 164 | $146,349 | $892 |
| Xarelto | 39 | $55,783 | $1,430 |
| Dofetilide | 122 | $48,164 | $395 |
| Multaq | 14 | $13,417 | $958 |
| Propafenone Hcl Er | 29 | $12,870 | $444 |
| Flecainide Acetate | 56 | $5,581 | $100 |
| Sotalol | 36 | $1,783 | $50 |
| Metoprolol | 69 | $1,521 | $22 |
| Diltiazem 24hr Er (Cd) | 25 | $673 | $27 |
| Amiodarone | 14 | $493 | $35 |
| Metoprolol | 43 | $338 | $8 |
| Pantoprazole | 32 | $305 | $10 |
| Prednisone | 13 | $40 | $3 |
2020: 10 drugs
| Eliquis | 135 | $105,488 | $781 |
| Xarelto | 44 | $48,848 | $1,110 |
| Dofetilide | 85 | $24,839 | $292 |
| Propafenone Hcl Er | 14 | $12,981 | $927 |
| Flecainide Acetate | 49 | $4,587 | $94 |
| Sotalol | 28 | $1,011 | $36 |
| Metoprolol | 44 | $918 | $21 |
| Diltiazem 24hr Er (Cd) | 32 | $793 | $25 |
| Pantoprazole | 21 | $195 | $9 |
| Metoprolol | 32 | $146 | $5 |
2019: 13 drugs
| Eliquis | 104 | $56,064 | $539 |
| Dofetilide | 116 | $49,846 | $430 |
| Xarelto | 27 | $18,505 | $685 |
| Propafenone Hcl Er | 12 | $2,560 | $213 |
| Flecainide Acetate | 38 | $2,290 | $60 |
| Metoprolol | 38 | $630 | $17 |
| Diltiazem 24hr Er (Cd) | 20 | $486 | $24 |
| Sotalol | 22 | $462 | $21 |
| Dilt-Xr | 13 | $319 | $25 |
| Carvedilol | 13 | $213 | $16 |
| Amiodarone | 13 | $191 | $15 |
| Pantoprazole | 15 | $137 | $9 |
| Metoprolol | 21 | $132 | $6 |
2018: 10 drugs
| Eliquis | 76 | $36,463 | $480 |
| Xarelto | 35 | $19,953 | $570 |
| Dofetilide | 36 | $18,633 | $518 |
| Propafenone Hcl Er | 11 | $4,041 | $367 |
| Flecainide Acetate | 15 | $1,563 | $104 |
| Metoprolol | 26 | $448 | $17 |
| Sotalol | 19 | $403 | $21 |
| Carvedilol | 20 | $81 | $4 |
| Cephalexin | 13 | $65 | $5 |
| Metoprolol | 11 | $27 | $2 |
2017: 8 drugs
| Eliquis | 61 | $33,970 | $557 |
| Dofetilide | 34 | $21,901 | $644 |
| Propafenone Hcl Er | 15 | $8,235 | $549 |
| Pradaxa | 11 | $7,076 | $643 |
| Flecainide Acetate | 41 | $2,087 | $51 |
| Metoprolol | 51 | $1,026 | $20 |
| Amiodarone | 11 | $199 | $18 |
| Cephalexin | 14 | $48 | $3 |
2016: 14 drugs
| Eliquis | 111 | $52,460 | $473 |
| Tikosyn | 67 | $46,114 | $688 |
| Dofetilide | 40 | $29,645 | $741 |
| Propafenone Hcl Er | 20 | $12,362 | $618 |
| Pradaxa | 24 | $10,899 | $454 |
| Xarelto | 18 | $10,070 | $559 |
| Metoprolol | 65 | $1,524 | $23 |
| Flecainide Acetate | 59 | $1,320 | $22 |
| Propafenone | 13 | $886 | $68 |
| Amiodarone | 19 | $330 | $17 |
| Sotalol | 17 | $236 | $14 |
| Cartia Xt | 11 | $134 | $12 |
| Carvedilol | 11 | $76 | $7 |
| Cephalexin | 14 | $57 | $4 |
2015: 10 drugs
| Tikosyn | 108 | $61,245 | $567 |
| Eliquis | 108 | $46,053 | $426 |
| Xarelto | 28 | $13,405 | $479 |
| Pradaxa | 17 | $9,045 | $532 |
| Propafenone Hcl Er | 11 | $6,809 | $619 |
| Metoprolol | 69 | $2,384 | $35 |
| Flecainide Acetate | 49 | $1,397 | $29 |
| Amiodarone | 18 | $1,272 | $71 |
| Carvedilol | 12 | $152 | $13 |
| Cephalexin | 27 | $97 | $4 |
2014: 15 drugs
| Tikosyn | 100 | $40,363 | $404 |
| Xarelto | 71 | $30,397 | $428 |
| Propafenone Hcl Er | 48 | $22,676 | $472 |
| Eliquis | 50 | $17,549 | $351 |
| Pradaxa | 44 | $16,400 | $373 |
| Metoprolol | 73 | $2,477 | $34 |
| Flecainide Acetate | 69 | $2,219 | $32 |
| Propafenone | 15 | $1,550 | $103 |
| Labetalol | 12 | $1,363 | $114 |
| Sotalol | 35 | $651 | $19 |
| Carvedilol | 15 | $345 | $23 |
| Atenolol | 16 | $112 | $7 |
| Metoprolol | 17 | $78 | $5 |
| Cephalexin | 12 | $51 | $4 |
| Hydrochlorothiazide | 11 | $22 | $2 |
2013: 13 drugs
| Tikosyn | 68 | $26,214 | $385 |
| Propafenone | 58 | $19,200 | $331 |
| Xarelto | 53 | $14,812 | $279 |
| Pradaxa | 28 | $7,297 | $261 |
| Metoprolol | 120 | $3,468 | $29 |
| Flecainide Acetate | 49 | $1,810 | $37 |
| Sotalol | 44 | $919 | $21 |
| Atorvastatin | 12 | $386 | $32 |
| Carvedilol | 14 | $235 | $17 |
| Verapamil Er | 15 | $162 | $11 |
| Atenolol | 11 | $120 | $11 |
| Metoprolol | 19 | $109 | $6 |
| Cephalexin | 14 | $64 | $5 |
Money from drug and device companies
$34,265 in 2025
| 2025 | 15 | 108 | $26,151 | $34,265 |
| 2024 | 8 | 76 | $19,300 | $25,025 |
| 2023 | 9 | 72 | $13,025 | $37,501 |
| 2022 | 12 | 57 | $5,475 | $10,315 |
| 2021 | 7 | 56 | $8,719 | $11,205 |
| 2020 | 13 | 69 | $24,533 | $27,979 |
| 2019 | 11 | 41 | $5,187 | $7,934 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Gallant | $17,749 | 55 payments
|
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $7,590 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $7,223 | 13 payments
|
| Medtronic | Affera Mapping System | $506 | 12 payments
|
| Biosense Webster | Carto 3 | $478 | 4 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $168 | 3 payments
|
See all 108 published payments
| AtriCure | Consulting · 2025-12-19 | Epi-Sense Guided Coagulation System With Visitrax | $7,500 |
| Biosense Webster | Meals · 2025-12-18 | Nuvision Ice Catheter | $98 |
| Boston Scientific | Meals · 2025-12-18 | Rhythmia Mapping System | $66 |
| Medtronic | Meals · 2025-12-18 | Affera Mapping System | $63 |
| Abbott Laboratories | Meals · 2025-12-17 | Ensite | $153 |
| Abbott Laboratories | Paid to speak or teach · 2025-12-12 | Gallant | $4,169 |
| Abbott Laboratories | Paid to speak or teach · 2025-12-12 | Gallant | $144 |
| Abbott Laboratories | Paid to speak or teach · 2025-12-12 | Gallant | $288 |
| Abbott Laboratories | Paid to speak or teach · 2025-12-12 | Gallant | $288 |
| Abbott Laboratories | Paid to speak or teach · 2025-12-12 | Gallant | $288 |
| Abbott Laboratories | Paid to speak or teach · 2025-12-12 | Gallant | $431 |
| Abbott Laboratories | Paid to speak or teach · 2025-12-12 | Gallant | $288 |
| Abbott Laboratories | Paid to speak or teach · 2025-12-12 | Gallant | $431 |
| Chiesi USA | Meals · 2025-12-12 | Kengreal | $28 |
| Medtronic | Meals · 2025-12-05 | Affera Mapping System | $110 |
| Medtronic | Meals · 2025-12-03 | Pulseselect | $10 |
| AGEPHA Pharma FZ | Meals · 2025-12-02 | Lodoco | $18 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-27 | Kerendia | $31 |
| Medtronic | Meals · 2025-11-26 | Pulseselect | $36 |
| Abbott Laboratories | Meals · 2025-11-09 | Gallant | $86 |
| Abbott Laboratories | Meals · 2025-11-09 | Gallant | $37 |
| Abbott Laboratories | Meals · 2025-11-09 | Gallant | $54 |
| Abbott Laboratories | Meals · 2025-11-08 | Gallant | $88 |
| Abbott Laboratories | Meals · 2025-11-08 | Gallant | $30 |
| Abbott Laboratories | Meals · 2025-11-08 | Gallant | $93 |
| Abbott Laboratories | Meals · 2025-11-08 | Gallant | $38 |
| Abbott Laboratories | Meals · 2025-11-08 | Gallant | $85 |
| Abbott Laboratories | Meals · 2025-11-08 | Gallant | $176 |
| Abbott Laboratories | Travel · 2025-11-08 | Gallant | $296 |
| Abbott Laboratories | Travel · 2025-11-07 | Gallant | $296 |
| Abbott Laboratories | Travel · 2025-11-07 | Gallant | $100 |
| Cordis US | Meals · 2025-11-06 | Mynx Control Venous | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Paid to speak or teach · 2025-10-22 | Lifevest | $2,500 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Travel · 2025-10-22 | Lifevest | $1,000 |
| Merck Sharp & Dohme | Meals · 2025-10-08 | Verquvo | $22 |
| Biosense Webster | Meals · 2025-10-07 | Carto 3 | $133 |
| Abbott Laboratories | Travel · 2025-10-07 | Aveir | $54 |
| Abbott Laboratories | Travel · 2025-10-07 | Aveir | $166 |
| Abbott Laboratories | Meals · 2025-10-03 | Ensite Precision | $14 |
| Abbott Laboratories | Meals · 2025-10-03 | Ensite Precision | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Travel · 2025-10-01 | Lifevest | $127 |
| Medtronic | Meals · 2025-10-01 | Pulseselect | $10 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-09-24 | Lifevest | $67 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Travel · 2025-09-23 | Lifevest | $238 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-09-23 | Lifevest | $97 |
| Abbott Laboratories | Meals · 2025-09-19 | Viewmate | $23 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Travel · 2025-09-17 | Lifevest | $610 |
| Chiesi USA | Meals · 2025-09-17 | Kengreal | $21 |
| Merck Sharp & Dohme | Meals · 2025-09-10 | Verquvo | $21 |
| Abbott Laboratories | Meals · 2025-09-10 | Ensite Precision | $87 |
| Novartis Pharmaceuticals | Meals · 2025-09-05 | Leqvio | $19 |
| Medtronic | Meals · 2025-09-03 | Pulseselect | $53 |
| Abbott Laboratories | Meals · 2025-08-18 | Aveir | $92 |
| Abbott Laboratories | Meals · 2025-08-18 | Aveir | $61 |
| Abbott Laboratories | Meals · 2025-08-18 | Aveir | $88 |
| Abbott Laboratories | Meals · 2025-08-18 | Aveir | $101 |
| Abbott Laboratories | Travel · 2025-08-18 | Aveir | $268 |
| Abbott Laboratories | Travel · 2025-08-18 | Aveir | $235 |
| Merck Sharp & Dohme | Meals · 2025-08-13 | Verquvo | $18 |
| Abbott Laboratories | Meals · 2025-08-12 | Ensite | $26 |
| Medtronic | Meals · 2025-07-21 | Affera Mapping System | $167 |
| Chiesi USA | Meals · 2025-07-18 | Kengreal | $21 |
| Medtronic | Meals · 2025-07-17 | Affera Mapping System | $14 |
| Medtronic | Meals · 2025-07-16 | Pulseselect | $8 |
| Merck Sharp & Dohme | Meals · 2025-07-09 | Verquvo | $22 |
| Abbott Laboratories | Meals · 2025-07-09 | Ensite Precision | $20 |
| Abbott Laboratories | Meals · 2025-07-09 | Ensite | $24 |
| Shockwave Medical | Meals · 2025-06-25 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $2 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Paid to speak or teach · 2025-06-25 | Lifevest | $1,500 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-06-16 | Lifevest | $136 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-06-16 | Lifevest | $21 |
| Abbott Laboratories | Meals · 2025-06-16 | Ensite Precision | $96 |
| Abbott Laboratories | Meals · 2025-06-12 | Ensite | $22 |
| Merck Sharp & Dohme | Meals · 2025-06-11 | Verquvo | $32 |
| Pfizer | Meals · 2025-06-03 | Vyndaqel | $20 |
| Abbott Laboratories | Meals · 2025-05-30 | Ensite Precision | $22 |
| Abbott Laboratories | Meals · 2025-05-30 | Ensite Precision | $120 |
| Abbott Laboratories | Consulting · 2025-05-27 | Tacticath Ablation Catheter, Sensor Enabled | $2,400 |
| Biosense Webster | Meals · 2025-05-23 | Carto 3 | $136 |
| Abbott Laboratories | Meals · 2025-05-22 | Tacticath Ablation Catheter, Sensor Enabled | $28 |
| Abbott Laboratories | Meals · 2025-05-14 | Ensite | $29 |
| Medtronic | Meals · 2025-05-09 | Pulseselect | $16 |
| Abbott Laboratories | Travel · 2025-05-06 | None | $546 |
| Abbott Laboratories | Travel · 2025-05-06 | None | $9 |
| AtriCure | Meals · 2025-04-26 | Synergy Ablation System | $90 |
| Biosense Webster | Meals · 2025-04-24 | Carto 3 | $110 |
| Abbott Laboratories | Meals · 2025-04-14 | Ensite Precision | $22 |
| Chiesi USA | Meals · 2025-04-11 | Kengreal | $20 |
| Shockwave Medical | Meals · 2025-04-09 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $37 |
| Abbott Laboratories | Meals · 2025-04-07 | Ensite | $6 |
| Abbott Laboratories | Meals · 2025-04-07 | Ensite | $6 |
| Abbott Laboratories | Meals · 2025-03-25 | None | $17 |
| Abbott Laboratories | Meals · 2025-03-25 | Ensite | $19 |
| Medtronic | Meals · 2025-03-14 | Micra | $10 |
| Merck Sharp & Dohme | Meals · 2025-03-12 | Verquvo | $21 |
| Novartis Pharmaceuticals | Meals · 2025-03-07 | Leqvio | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Paid to speak or teach · 2025-03-05 | Lifevest | $750 |
| Medtronic | Meals · 2025-03-05 | Azure Xt Dr Mri Surescan | $8 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-02-25 | Lifevest | $163 |
| Abbott Laboratories | Meals · 2025-02-20 | Ensite Precision | $21 |
| Merck Sharp & Dohme | Meals · 2025-02-12 | Verquvo | $21 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-02-05 | Lifevest | $14 |
| Kestra Medical Technology Services | Meals · 2025-01-31 | Assure Wcd | $109 |
| Abbott Laboratories | Consulting · 2025-01-29 | Tacticath Ablation Catheter, Sensor Enabled | $2,400 |
| Abbott Laboratories | Meals · 2025-01-22 | Ensite Precision | $11 |
| Shockwave Medical | Meals · 2025-01-18 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $129 |
| Abbott Laboratories | Consulting · 2025-01-15 | Tacticath Ablation Catheter, Sensor Enabled | $2,776 |
| Abbott Laboratories | Meals · 2025-01-14 | Ensite Precision | $65 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $25,025
| Abbott Laboratories | Gallant | $14,926 | 46 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $8,222 | 11 payments
|
| Atricure | Atriclip Laa Exclusion System | $1,068 | 4 payments
|
| Medtronic | Micra | $371 | 5 payments
|
| Cardiva Medical | Ensoetm | $110 | 1 payment
|
| Amgen | Repatha | $110 | 4 payments
|
| Novartis Pharmaceuticals | Entresto | $110 | 4 payments
|
| Biotronik | Acticor 7 Vr-T Dx | $107 | 1 payment
|
2023: $37,501
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $15,261 | 9 payments
|
| Abbott Laboratories | Gallant | $12,026 | 37 payments
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $9,114 | 2 payments
|
| Medtronic | Selectsecure | $656 | 6 payments
|
| Novartis Pharmaceuticals | Leqvio | $160 | 6 payments
|
| Amgen | Repatha | $95 | 4 payments
|
| Merck Sharp & Dohme | Verquvo | $93 | 4 payments
|
| Chiesi USA | Kengreal | $71 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $23 | 1 payment
|
2022: $10,315
| Abbott Laboratories | Aveir | $4,200 | 28 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $3,899 | 4 payments
|
| Biosense Webster | Carto 3 | $1,602 | 4 payments
|
| Medtronic | Micra | $125 | 1 payment
|
| AtriCure | Synergy Ablation System | $111 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $100 | 5 payments
|
| Chiesi USA | Kengreal | $69 | 5 payments
|
| Novartis Pharmaceuticals | Entresto | $65 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $50 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $47 | 2 payments
|
| Kiniksa Pharmaceuticals | Arcalyst | $27 | 1 payment
|
| Boston Scientific | Eluvia | $19 | 1 payment
|
2021: $11,205
| Abbott Laboratories | Confirm Rx | $7,121 | 29 payments
|
| Medical Device Business Services | Carto 3 | $3,600 | 1 payment
|
| Chiesi USA | Kengreal | $202 | 15 payments
|
| Boston Scientific | Ekosonic | $111 | 6 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $107 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $40 | 2 payments
|
| Medtronic | In.Pact Admiral | $25 | 2 payments
|
2020: $27,979
| Abbott Laboratories | Ensite Cardiac Mapping System | $13,293 | 19 payments
|
| Biosense Webster | Carto 3 System | $5,864 | 7 payments
|
| Medical Device Business Services | Carto 3 System | $4,076 | 8 payments
|
| Sanofi-Aventis U.S. | None | $3,956 | 1 payment
|
| Chiesi USA | Kengreal 50mg/10ml L | $186 | 15 payments
|
| Boston Scientific | Resonate | $163 | 2 payments
|
| Medtronic Vascular | Micra | $144 | 3 payments
|
| Amgen | Corlanor | $85 | 4 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $65 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $51 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $45 | 3 payments
|
| Terumo Medical | Glidesheath | $34 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $19 | 1 payment
|
2019: $7,934
| Abbott Laboratories | Ensite Cardiac Mapping System | $6,995 | 20 payments
|
| Biotronik | None | $213 | 3 payments
|
| Medtronic Vascular | Visia Af | $183 | 2 payments
|
| Boston Scientific | General Ep | $134 | 3 payments
|
| Biosense Webster | Carto 3 System | $127 | 1 payment
|
| Philips Electronics North America | Igt D Peripheral | $87 | 2 payments
|
| Chiesi USA | Kengreal | $58 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $51 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $38 | 2 payments
|
| Amgen | Repatha | $30 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $20 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| ATRICURE, INC. · Left Atrial Appendage Ligation With the Lariat Suture Delivery System As Adjunctive Therapy To Pulmonary Vein Isolation for Persistent Or Longstanding Persisten Atrial Fibrillation · 2019 | Their institution | $111,535 |
| ATRICURE, INC. · Left Atrial Appendage Ligation With the Lariat Suture Delivery System As Adjunctive Therapy To Pulmonary Vein Isolation for Persistent Or Longstanding Persistant Atrial Fibrillation (Amaze Study) · 2021 | Their institution | $24,214 |
| ATRICURE, INC. · Nonrandomized Multicenter Expanded Use Evaluation of the Lariat Suture Delivery Device Appendix 16 To Ongoing Investigation · 2023 | Their institution | $20,799 |
| ATRICURE, INC. · Pivotal Study of A Dual Epicardial & Endocardial Procedure (Deep) Approach for Treatment of Subjects With Persistent Or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation · 2021 | Their institution | $16,375 |
| ATRICURE, INC. · Left Atrial Appendage Ligation With the Lariat Suture Delivery System As Adjunctive Therapy To Pulmonary Vein Isolation for Persistent Or Longstanding Persistent Atrial Fibrillation · 2022 | Their institution | $15,948 |
| ATRICURE, INC. · Pivotal Study of A Dual Epicardial and Endocardial Procedure Deep Approach for Treatment of Subjects With Persistent Or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation · 2024 | Their institution | $15,513 |
| ATRICURE, INC. · Pivotal Study of A Dual Epicardial & Endocardial Procedure Deep Approach for Treatment of Subjects With Persistent Or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation · 2023 | Their institution | $12,227 |
| ATRICURE, INC. · Hybrid Epicardial and Endocardial Sinus Node Sparing Ablation Therapy for Inappropriate Sinus Tachycardia · 2024 | Their institution | $8,589 |
| ATRICURE, INC. · Amaze Trial Continued Access Protocol (Amaze Cap) · 2021 | Their institution | $5,810 |
| ATRICURE, INC. · Left Atrial Appendage Ligation With the Lariat Suture Delivery System As Adjunctive Therapy To Pulmonary Vein Isolation for Persistent Or Longstanding Persistant Atrial Fibrillation (Amaze Study) · 2020 | Their institution | $5,178 |
| ATRICURE, INC. · Nonrandomized Multicenter Expanded Use Evaluation of the Lariat Suture Delivery Device Appendix 16 To Ongoing Investigation · 2024 | Their institution | $2,489 |
| ATRICURE, INC. · Pivotal Study of A Dual Epicardial & Endocardial Procedure (Deep) Approach for Treatment of Subjects With Persistent Or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation · 2020 | Their institution | $1,969 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1619928892
- Licence
- CA A76074California A76074: Current · expires 2028-10-31
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A760740
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Cardiology (207RC0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-05-13
- NPI last updated
- 2024-04-17
- NPI record certified
- 2024-04-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 350 Parnassus Ave, San Francisco, CA, 94143 · 300 Pasteur Dr Rm H2146a, Stanford, CA, 94305